Evaluating Dose Escalation to 60 Gy in Locally Advanced Esophageal Squamous Cell Carcinoma
Trial shows higher radiation dose does not improve cancer survival
A Phase 3 trial compares 60 Gy versus 50 Gy of radiotherapy with concurrent chemotherapy for patients with unresectable esophageal squamous …
A large trial shows that increasing radiation doses for advanced esophageal cancer does not improve survival but may increase side effects.
Small bowel metastasis from esophageal squamous cell carcinoma shows male predominance and 6-month median survival
Small bowel spread from esophageal cancer has a short survival window
This systematic review of 23 patients with small bowel metastasis from esophageal squamous cell carcinoma found a strong male predominance (…
Patients with esophageal cancer that spreads to the small bowel often face a short survival window of about 6 months after diagnosis.
Toripalimab plus paclitaxel and cisplatin improves overall survival in advanced esophageal squamous-cell carcinoma
Trial shows toripalimab improves survival for advanced esophageal cancer
This Phase 3 randomized controlled trial of 514 treatment-naïve patients with advanced esophageal squamous-cell carcinoma found that toripal…
A new combination therapy involving toripalimab and chemotherapy significantly extended survival for patients with advanced esophageal squam…
Postoperative radiotherapy improves survival and reduces recurrence in resected ESCC
Radiotherapy After Surgery Improves Survival for Esophageal Squamous Cell Carcinoma
This meta-analysis of 11,385 patients with radically resected esophageal squamous cell carcinoma found that postoperative radiotherapy (PORT…
Adding radiation after surgery can improve survival rates and reduce local cancer recurrence for patients with esophageal squamous cell carc…
Camrelizumab and apatinib show higher response rates and survival in treatment-naive patients with ESCC
Treatment Naive Patients Show Better Survival with Camrelizumab and Apatinib
This meta-analysis evaluates the efficacy of camrelizumab plus apatinib for advanced or metastatic esophageal squamous cell carcinoma. The a…
Patients with advanced esophageal cancer who have not had prior treatment may see better survival rates when using a combination of camreliz…
Sintilimab may trigger autoimmune GFAP astrocytopathy in esophageal squamous cell carcinoma patients
New cancer treatment may cause rare brain inflammation in patients
This case report and literature review describes a patient with advanced esophageal squamous cell carcinoma who developed autoimmune GFAP as…
A new type of immunotherapy for esophageal cancer can trigger a rare brain condition, requiring doctors to watch for early signs of neurolog…
Neoadjuvant chemoimmunotherapy improves pathological response and surgical rates in resectable esophageal squamous cell carcinoma
Immune therapy shows promise for esophageal squamous cell carcinoma
This meta-analysis of randomized controlled trials involving 1070 patients found that neoadjuvant chemoimmunotherapy (NIC) significantly imp…
Adding immune checkpoint inhibitors to chemotherapy before surgery significantly improves tumor response rates in patients with esophageal c…
High PTTG1 expression correlates with poorer survival and advanced disease in various solid tumors
High levels of PTTG1 protein linked to worse cancer outcomes
This meta-analysis of 22 studies from 21 articles analyzed the prognostic value of PTTG1 expression across multiple solid tumors. High PTTG1…
A review of 22 studies shows that high levels of the PTTG1 protein are linked to shorter survival times in several types of solid tumors.
Robot-assisted oesophagectomy shows non-inferior survival in oesophageal squamous cell carcinoma
Robot-assisted surgery may improve survival for oesophageal cancer patients
A randomised trial compared robot-assisted versus thoracoscopic oesophagectomy for resectable oesophageal squamous cell carcinoma. The autho…
A large trial found robot-assisted oesophagectomy linked to higher five-year survival than thoracoscopic surgery for oesophageal squamous ce…
Meta-analysis finds sex-based differences in ICI survival benefit for advanced gastroesophageal cancer
Immunotherapy Works Differently for Men and Women with Stomach Cancer
This meta-analysis of 15 RCTs examined immune-checkpoint inhibition for advanced gastroesophageal cancer. It found a significant overall sur…
Men with esophageal cancer gain a clear survival edge from immunotherapy, while women do not, but both sexes benefit similarly in stomach ca…
Meta-analysis shows neoadjuvant chemoradiation improves resection and survival outcomes for esophageal squamous cell carcinoma patients compared to chemotherapy alone
Adding radiation before surgery helps some esophageal cancer patients get better surgery results and live longer
This meta-analysis of 2,174 patients reveals that adding radiation to chemotherapy significantly boosts resection rates and survival for squ…
A large review found that adding radiation to chemotherapy before surgery helped remove more tumors in certain cancer types. This approach a…
GERD Associated with Increased Risk of Laryngeal Cancer in Meta-Analysis
Large study links GERD to higher risk of laryngeal cancer
A systematic review and meta-analysis of 1,768,394 adults found that gastroesophageal reflux disease (GERD) was significantly associated wit…
A massive analysis of nearly 1.8 million adults found a link between gastroesophageal reflux disease and increased risk of laryngeal cancer.
Research across Head and Neck Cancer
Related studies from across the Head and Neck Cancer family.
Post-operative ctDNA linked to worse survival in HPV-negative HNSCC, but estimate unstable
ctDNA levels may signal cancer return in head and neck cancer
This meta-analysis examined post-operative ctDNA as a prognostic marker in HPV-negative head and neck squamous cell carcinoma. Detectable ct…
Detecting traces of cancer DNA in the blood after surgery may help identify patients at higher risk of cancer returning.
YAP and TAZ Overexpression Predicts Worse Survival in Oral Squamous Cell Carcinoma
Hippo Pathway Markers Linked to Oral Cancer Survival Rates
This meta-analysis of 17 studies examined the prognostic value of Hippo pathway effectors YAP and TAZ in oral squamous cell carcinoma. Poole…
New data suggests that specific proteins in the Hippo pathway may help predict survival outcomes for patients with oral squamous cell carcin…
Cisplatin Chemoradiotherapy for Elderly Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
New trial tests chemotherapy for elderly patients with head cancer
This trial protocol describes a study evaluating the use of weekly cisplatin in elderly patients with locally advanced squamous cell carcino…
A new trial aims to see if adding a specific chemotherapy drug helps elderly patients with advanced head and neck cancer.
Retropharyngeal lymph node involvement in oropharyngeal squamous cell carcinoma occurs in 11% to 16% of patients
Retropharyngeal lymph node involvement impacts staging for throat cancer
This meta-analysis of 8,887 patients with oropharyngeal squamous cell carcinoma (OPSCC) identified a pooled prevalence of retropharyngeal ly…
New data shows that certain lymph nodes in the throat area are more likely to spread cancer in specific types of throat cancer cases.
Response-adapted surgery after neoadjuvant immune checkpoint inhibitors improves pathologic complete response in mucosal HNSCC
Response-Adapted Surgery May Help Preserve Organs in Head Cancer
This meta-analysis of patients with resectable mucosal head and neck squamous cell carcinoma (HNSCC) found that response-adapted surgery (RA…
A new approach to surgery after immunotherapy may help patients with head and neck cancer keep more of their natural tissue and function.
Smoking history linked to worse survival in HPV-positive oropharyngeal cancer after TORS
Smoking History Linked to Worse Survival in Throat Cancer
In HPV-associated oropharyngeal cancer treated with transoral robotic surgery, smoking history was tied to worse overall survival, though re…
A history of smoking is linked to a higher risk of death for patients with certain types of throat cancer treated with robotic surgery.
Oral HPV reshapes mucosal microbial composition in a sex and population dependent manner
Oral and genital health linked to specific bacteria and HPV
This mini-review synthesizes evidence regarding the interaction between HPV infection and mucosal microbiota in oral, anorectal, and penile …
New research shows how specific bacteria and the HPV virus interact in the mouth and genital areas to influence cancer risk.
Weekly Cisplatin Regimen Shows Noninferiority to Standard Dosing in Head and Neck Cancer
Weekly cisplatin treatment shows promise for head and neck cancer
A randomized trial confirms that weekly cisplatin dosing achieves noninferiority in overall survival for high-risk squamous cell carcinoma p…
A new trial shows that giving chemotherapy weekly instead of every three weeks may offer a comparable survival rate for head and neck cancer…
SMMI framework provides a conceptual model for risk stratification in high-risk oral potentially malignant disorders
New Framework Helps Identify Risk of Oral Cancer Development
This evidence-ranked conceptual review proposes the spatial-microbial-metabolic-immune (SMMI) framework to study malignant transformation ri…
A new conceptual framework looks at how microbes and the immune system might help doctors better identify high risk for oral cancer developm…
Distinct microbial taxa and functional pathways are associated with oral squamous cell carcinoma
Specific Bacteria Linked to Oral Squamous Cell Carcinoma
This meta-analysis identifies specific microbial taxa and functional pathways associated with oral squamous cell carcinoma. The findings hig…
Researchers identified specific types of bacteria and genetic pathways that are more common in people with oral squamous cell carcinoma.
Plant extracts like curcumin and resveratrol may inhibit HNSCC growth via specific signaling pathways
Plant extracts may slow growth of head and neck cancer
This systematic review examines the effects of plant extracts, including resveratrol, curcumin, quercetin, and anthocyanins, on head and nec…
Certain plant compounds like curcumin and resveratrol show promise in stopping cancer cell growth and resisting chemotherapy in lab studies.
Submental Artery Island Flap Shows 16% Pooled Locoregional Recurrence in Oral Cavity Reconstruction
Submental artery island flap is a safe option for oral cancer
This meta-analysis pooled data on the submental artery island flap (SAIF) for oral cavity defects after oral squamous cell carcinoma resecti…
A specific surgical technique called the submental artery island flap shows a low recurrence rate for patients with oral cavity defects.
Questions about Esophageal Squamous Cell Carcinoma
How does neoadjuvant chemoimmunotherapy change the tumor environment in esophageal squamous cell carcinoma?
Neoadjuvant chemoimmunotherapy remodels the tumor microenvironment in ESCC by increasing cytotoxic CD8+ T cells, dendritic cell remodeling, and reducing tumor volume, which correlates with better pathological response and survival.
Full answer →Does gastroesophageal reflux disease increase the risk of laryngeal cancer or esophageal squamous cell carcinoma?
GERD increases the risk of laryngeal cancer but not esophageal squamous cell carcinoma, according to a large meta-analysis.
Full answer →Is S-1 medication better than radiation alone for elderly patients with esophageal squamous cell carcinoma?
Yes, S-1 plus radiation improves survival over radiation alone for elderly patients with inoperable esophageal squamous cell carcinoma, based on a phase III trial.
Full answer →Can a deep learning model help diagnose esophageal squamous cell carcinoma more accurately?
Yes, deep learning models can help diagnose esophageal squamous cell carcinoma more accurately, with studies showing high AUC values for tumor detection and lymph node metastasis prediction.
Full answer →Does adding radiation to chemotherapy help esophageal squamous cell carcinoma patients live longer?
Adding radiation to chemotherapy before surgery does not clearly improve overall survival for esophageal squamous cell carcinoma patients compared to chemotherapy alone, but it increases the chance of a complete tumor response.
Full answer →All Esophageal Squamous Cell Carcinoma Articles
- Evaluating Dose Escalation to 60 Gy in Locally Advanced Esophageal Squamous Cell Carcinoma
- Small bowel metastasis from esophageal squamous cell carcinoma shows male predominance and 6-month median survival
- Toripalimab plus paclitaxel and cisplatin improves overall survival in advanced esophageal squamous-cell carcinoma
- Postoperative radiotherapy improves survival and reduces recurrence in resected ESCC
- Camrelizumab and apatinib show higher response rates and survival in treatment-naive patients with ESCC
- Sintilimab may trigger autoimmune GFAP astrocytopathy in esophageal squamous cell carcinoma patients
- Neoadjuvant chemoimmunotherapy improves pathological response and surgical rates in resectable esophageal squamous cell carcinoma
- High PTTG1 expression correlates with poorer survival and advanced disease in various solid tumors
- Robot-assisted oesophagectomy shows non-inferior survival in oesophageal squamous cell carcinoma
- Meta-analysis finds sex-based differences in ICI survival benefit for advanced gastroesophageal cancer
- Meta-analysis shows neoadjuvant chemoradiation improves resection and survival outcomes for esophageal squamous cell carcinoma patients compared to chemotherapy alone
- Review of multimodal deep learning model for esophageal squamous cell carcinoma diagnosis
- SIB-RT plus S-1 improves survival in elderly inoperable esophageal cancer
- GERD Associated with Increased Risk of Laryngeal Cancer in Meta-Analysis
- Deep learning segmentation with CT elasticity features predicts right recurrent laryngeal nerve metastasis in esophageal cancer
- Neoadjuvant Chemoimmunotherapy Alters Tumor Microenvironment in Esophageal Cancer
- Timing of surgery after neoadjuvant chemoimmunotherapy impacts survival in operable esophageal squamous cell carcinoma
- PD-1 inhibitors + chemo improve OS, PFS, ORR in first-line advanced ESCC; benefit limited in PD-L1 CPS <1